Evidence map›Paper›PMID 35328624›Full record

ReviewInternational journal of molecular sciences2022

Preventing Bacterial Translocation in Patients with Leaky Gut Syndrome: Nutrition and Pharmacological Treatment Options.

Agata Twardowska, Adam Makaro, Agata Binienda, Jakub Fichna, Maciej Salaga

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The Roles of Gut Microbiota in the Pathogenesis of Acute Pancreatitis.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Agata TwardowskaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, 90-419 Lodz, Poland.
Adam MakaroDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0002-0695-9808
Agata BiniendaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0002-1173-2966
Jakub FichnaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0002-8443-4417
Maciej SalagaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0002-5917-8749
Medical University of Lodz · PL

Funding

Foundation for Polish Science POIR.04.04.00-00-420C/17-00Medical University of Lodz 503/1-156-04/503-11-001Ministry of Education and Science 0229/DIA/2019/48
6 · The paper itself

Abstract

Leaky gut syndrome is a medical condition characterized by intestinal hyperpermeability. Since the intestinal barrier is one of the essential components maintaining homeostasis along the gastrointestinal tract, loss of its integrity due to changes in bacterial composition, decreased expression levels of tight junction proteins, and increased concentration of pro-inflammatory cytokines may lead to intestinal hyperpermeability followed by the development of gastrointestinal and non-gastrointestinal diseases. Translocation of microorganisms and their toxic metabolites beyond the gastrointestinal tract is one of the fallouts of the leaky gut syndrome. The presence of intestinal bacteria in sterile tissues and distant organs may cause damage due to chronic inflammation and progression of disorders, including inflammatory bowel diseases, liver cirrhosis, and acute pancreatitis. Currently, there are no medical guidelines for the treatment or prevention of bacterial translocation in patients with the leaky gut syndrome; however, several studies suggest that dietary intervention can improve barrier function and restrict bacteria invasion. This review contains current literature data concerning the influence of diet, dietary supplements, probiotics, and drugs on intestinal permeability and bacterial translocation.

Indexed as

Gastrointestinal MicrobiomePancreatitisAcute DiseaseBacteriaBacterial TranslocationHumansIntestinal Mucosabacterial translocationleaky gut syndromenutrientsprobiotics

Identifiers

PMID35328624
PMCPMC8949204
OpenAlexW4221033948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.